26 January 2021>: Clinical Research
Predictive Value of a Thyroid-Absorbed Dose with a Shorter Effective Half-Life on Efficacy in Graves Disease Patients Receiving Iodine-131 Therapy
Feng Yu BCEF , Ruiguo Zhang CDF , Guizhi Zhang B , Zhaowei Meng B , Xiaohua Liu B , Yajing He B , Jian Tan D , Renfei Wang ADG*DOI: 10.12659/MSM.928796
Med Sci Monit 2021; 27:e928796
Table 1 The efficacy after a single RIT for GD patients with shorter Teff.
Teff | Efficacy: n (%) | Total effectiveness | |||
---|---|---|---|---|---|
Euthyroidism | Hypothyroidism | PR | NR or recurrence | ||
≤3d | 5 (16.1) | 0 (0.0) | 12 (38.7) | 14 (45.2) | 17 (54.8) |
3–5d | 68 (38.4) | 69 (39.0) | 38 (21.5) | 2 (1.1) | 175 (98.9) |
Total | 73 (35.1) | 69 (33.2) | 50 (24.0) | 16 (7.7) | 192 (92.3) |